Potency and selectivity of the tachykinin NK3 receptor antagonist SR 142801

European Journal of Pharmacology

Volumn 319, Issue 2-3, 1997, Pages 307-316

  Beaujouan, Jean Claude ^a   Saffroy, Monique ^a   Torrens, Yvette ^a   Glowinski, Jacques ^a  

^a INSERM   (France)

Author keywords

Ileum, guinea pig; Inositol monophosphate accumulation; Nonpeptide tachykinin NK3 receptor antagonist; Species difference; Tachykinin; Tachykinin NK3 receptor

Indexed keywords

INOSITOL PHOSPHATE; NEUROKININ 3 RECEPTOR ANTAGONIST; NEUROKININ A [4-10]; OSANETANT; SENKTIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GUINEA PIG; ILEUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SPECIES DIFFERENCE; STEREOSPECIFICITY;

ANIMALS; CHO CELLS; CRICETINAE; GUINEA PIGS; HUMANS; ILEUM; INOSINE MONOPHOSPHATE; MALE; MEMBRANES; MESOCRICETUS; PHOSPHOLIPASE C; PIPERIDINES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-2; RECEPTORS, NEUROKININ-3; SPECIES SPECIFICITY;

EID: 0031016039     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00848-5     Document Type: Article

References (39)

1. 2) receptor revisited with SR 48968, a potent non-peptide antagonist, Biochem. Biophys. Res. Commun. 184, 1418.
2. Beaujouan, J.C., Y. Torrens, A. Viger and J. Glowinski, 1984, A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivative, Mol. Pharmacol. 26, 248.
3. Bergström, L., J.C. Beaujouan, Y. Torrens, M. Saffroy, J. Glowinski, S. Lavielle, G. Chassaing, A. Marquet, P. D'Orléans-Juste, S. Dion and D. Regoli, 1987, H-Neurokinin A labels a specific tachykinin-binding site in the rat duodenal smooth muscle, Mol. Pharmacol. 32, 764.
4. Bristow, D.R., N.R. Curtis, N. Suman-Chauhan, K.J. Watling and B.J. Williams, 1987, Effects of tachykinins on inositol phospholipid hydrolysis in slices of hamster urinary bladder, Br. J. Pharmacol. 90, 211.
5. Buell, G., M.F. Schulz, S.J. Arkinstall, K. Maury, M. Missotten, N. Adami, F. Talabot and E. Kawashima, 1992, Molecular characterisation, expression and localisation of human neurokinin 3 receptor, FEBS Lett. 299, 90.
6. Burcher, E. and S.H. Buck, 1986, Multiple tachykinin binding sites in hamster, rat and guinea-pig urinary bladder, Eur. J. Pharmacol. 128, 165.
7. Chassaing, G., S. Lavielle, S. Julien and A. Marquet, 1985, Homocysteine thiolactone as precursor of methionine amide: application to the modification of peptides of the tachykinin family, Tetrahedron Lett. 26, 623.
8. 3 receptors, Biochem. Biophys. Res. Commun. 198, 967.
9. Chung, F.Z., L.H. Wu, Y. Tian, M.A. Vartanian, H. Lee, J. Bikker, C. Humblet, M.C. Pritchard, J. Raphy, N. Suman-Chauhan, D.C. Hoewell, N.D. Lalwani and D.L. Oxender, 1995, Two classes of structurally different antagonists display similar species preference for the human tachykinin neurokinin3 receptor, Mol. Pharmacol. 48, 711.
10. Dietl, M.M. and J.M. Palacios, 1991, Phylogeny of tachykinin receptor localization in the vertebrate central nervous system: apparent absence of neurokinin-2 and neurokinin-3 binding sites in the human brain, Brain Res. 539, 211.
11. 3 receptor, Life Sci. 56, 27.
12. Glowinski, J., 1995, The 'septide-sensitive' tachykinin receptor: still an enigma, Trends Pharmacol. Sci. 16, 365.
13. 3-receptors are linked to inositol phospholipid hydrolysis in the guinea-pig ileum longitudinal muscle-myenteric plexus preparation, Br. J. Pharmacol. 94, 148.
14. 3 tachykinin receptors in guinea-pig ileum longitudinal muscle-myenteric plexus and cerebral cortex membranes, Br. J. Pharmacol. 99, 767.
15. Hall, J.M., M.P. Caulfield, S.P. Watson and S. Guard, 1993, Receptor subtypes or species homologues: relevance to drug discovery, Trends Pharmacol. Sci. 14, 376.
16. Kenakin, T., 1993, Pharmacologic Analysis of Drug-Receptor Interaction, 2nd edn. (Raven Press, New York).
17. Laufer, R., U. Wormser, Z.Y. Friedman, C. Gilon, M. Chorev and Z. Selinger, 1985, Neurokinin B is a preferred agonist for a neuronal substance P receptor and its action is antagonized by enkephalin, Proc. Natl. Acad. Sci. USA 82, 7444.
18. Maggi, C.A., 1995, The mammalian tachykinin receptors, Gen. Pharmacol. 26, 911.
19. 2 receptors, J. Pharmacol. Exp. Ther. 271, 1489.
20. 1 receptor subtypes in the rat urinary bladder, Br. J. Pharmacol. 111, 739.
21. 2 receptor selectivity, J. Pharmacol. Exp. Ther. 262, 398.
22. Nguyen, Q.T., D. Jukic, L. Chrétien, F. Gobeil, M. Boussougou and D. Regoli, 1994, Two NK-3 receptor subtypes: demonstration by biological and binding assays, Neuropeptides 27, 157.
23. Oury-Donat, F., P. Carayon, O. Thurneyssen, V. Pailhon, X. Emonds-Alt, P. Soubrié and G. Le Fur, 1995, Functional characterization of the nonpeptide neurokinin 3 (NK3) receptor antagonist, SR142801 on the human tachykinin NK3 receptor expressed in Chinese hamster ovary cells, J. Pharmacol. Exp. Ther. 274, 148.
24. Patacchini, R. and C. A. Maggi, 1995, Tachykinin receptors and receptors subtypes, Arch. Int. Pharmacodyn. 329, 161.
25. Patacchini, R., L. Bartho, P. Holzer and C.A. Maggi, 1995, Activity of SR 142801 at peripheral tachykinin receptors, Eur. J. Pharmacol. 278, 17.
26. 9]-substance P is a potent and selective ligand of NK-1 tachykinin receptor, J. Neurochem. 56, 879.
27. Petitet, F., M. Saffroy, Y. Torrens, S. Lavielle, G. Chassaing, D. Loeuillet, J. Glowinski and J.C. Beaujouan, 1992, Possible existence of a new tachykinin receptor subtype in the guinea-pig ileum, Peptides 13, 383.
28. Petitet, F., J.-C. Beaujouan, M. Saffroy, Y. Torrens and J. Glowinski, 1993a, The nonpeptide NK-2 antagonist SR 48968 is also a NK-3 antagonist in the guinea pig but not in the rat, Biochem. Biophys. Res. Commun. 191, 180.
29. Petitet, F., J.-C. Beaujouan, M. Saffroy, Y. Torrens, V. Fardin and J. Glowinski, 1993b, NK-1 tachykinin receptor in rat and guinea pig brains: pharmacological and autoradiographical evidence for a species difference, Peptides 14, 551.
30. 3 receptors based on inositol monophosphate accumulation in the guinea pig ileum, Eur. J. Pharmacol. Mol. Pharmacol. Sect. 247, 185.
31. 3 receptors, Eur. J. Pharmacol. Mol. Pharmacol. Sect. 269, 73.
32. Regoli, D., A. Boudon and J.-L. Fauchère, 1994, Receptors and antagonists for substance P and related peptides, Pharmacol. Rev. 46, 551.
33. Sagan, S., G. Chassaing, L. Pradier and S. Lavielle, 1996, Tachykinin peptides affect differently the second messenger pathways after binding to CHO-expressed human NK-1 receptors, J. Pharmacol. Exp. Ther. 276, 1039.
34. 3 receptors: evidence for interspecies variance, Eur. J. Pharmacol. Mol. Pharmacol. Section 269, 65.
35. Torrens, Y., J.-C. Beaujouan, M. Dietl, M. Saffroy, F. Petitet and J. Glowinski, 1991, Tachykinin receptors: binding and cellular activity assays, Methods Neurosci. 5, 243.
36. Torrens, Y., J.-C. Beaujouan, M. Saffroy and J. Glowinski, 1995, Involvement of septide-sensitive tachykinin receptors in inositol phospholipid hydrolysis in the rat urinary bladder, Peptides 16, 587.
37. Tsuchida, K., R. Shigemoto, Y. Yokota and S. Nakanishi, 1990, Tissue distribution and quantitation of the mRNAs for three rat tachykinin receptors, Eur. J. Biochem. 193, 751.
38. 125I-substance P derivative to rat brain synaptosomes, J. Neurochem. 40, 1030.
39. Wormser, U., R. Laufer, Y. Hart, M. Chorev, C. Gilon and Z. Selinger, 1986, Highly selective agonists for substance P receptor subtypes, EMBO J. 5, 2805.